Congenital erythrocytosis

Area of Science:

• Hematology
• Genetics
• Pediatrics

Background:

• Congenital erythrocytosis is a rare condition present at birth, often diagnosed in childhood or early adulthood.
• It can be primary, involving erythroid compartment defects, or secondary, caused by increased erythropoietin production.
• Family history may be present in affected individuals.

Purpose of the Study:

• To review the causes, diagnostic approaches, and management of congenital erythrocytosis.
• To highlight the role of molecular investigations in identifying genetic defects.
• To discuss potential complications and therapeutic strategies.

Main Methods:

• Review of primary causes including erythropoietin receptor mutations.
• Investigation of congenital secondary causes involving oxygen-sensing pathways and abnormal hemoglobin oxygen affinity.
• Diagnostic procedures include erythropoietin levels, oxygen dissociation curves, hemoglobin electrophoresis, and gene sequencing.

Main Results:

• Identification of known or novel molecular variants confirms congenital erythrocytosis.
• Nonspecific symptoms can occur, and major thromboembolic events have been reported.
• Therapeutic options include low-dose aspirin and venesection.

Conclusions:

• Congenital erythrocytosis is a rare condition often presenting in young individuals.
• Molecular investigations can identify underlying genetic lesions.
• In a majority of cases, no specific genetic defect is currently identified.